Maternal Serum Screen 3; Triple Test in Pitampura & Rohini

MATERNAL SERUM SCREEN 3; TRIPLE TEST  

Special Instruction : Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).

Parameters covered : 3

Report Frequency :  Sample Mon through Sat by 9 am; Report Same day

MATERNAL SERUM SCREEN 3; TRIPLE TEST- Overview

What is MATERNAL SERUM SCREEN 3; TRIPLE TEST ?

Maternal Serum Screen 3; Triple Test is a second-trimester prenatal screening blood test that assesses the risk of certain fetal conditions. It measures three biochemical markers in a maternal blood sample: Total β-hCG, Alpha-Fetoprotein (AFP), and Estriol (E3). The results are interpreted with factors such as gestational age to estimate risk for conditions including Down syndrome, trisomy 18, and neural tube defects. It is a screening test, not a diagnostic test.

Doctor Information

Pre-test Information

Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).

Report Delivery

Sample Mon through Sat by 9 am; Report Same day

Category

Prenatal Diagnosis

Stability Room

6 hrs

Stability Refrigerated

1 week

Stability Frozen

1 week

Method

CLIA

Specimen

3 mL (1.5 mL min.) Serum from 1 SST. Ship refrigerated or frozen.

Usage

Triple Screen test is used for Prenatal Screening of Down Syndrome (Trisomy 21), Edward’s Syndrome (Trisomy 18) and Open Neural Tube Defects. The approximate detection rate with this test is 55–65% with a false positive rate of 5%.

Maternal Serum Screen 3; Triple Test in Pitampura & Rohini: A Clear Guide to Prenatal Screening

Pregnancy involves numerous consultations and medical jargon, which can often make the concept of a blood test seem a little more intimidating than it actually is. Maternal serum screening provides a method of calculating the probability of various fetal abnormalities. The Maternal Serum Screen 3; Triple Test at Pitampura involves the testing of three biochemical indicators obtained from maternal blood during the second trimester. Support with lab tests is provided by Bio Diagnostics at Pitampura and Rohini.

What Is the Maternal Serum Triple Test?

Maternal Serum Screen 3; Triple Test in Pitampura is a screening blood test which includes measuring the levels of Total β-hCG, AFP, and E3. It indicates the risk of the presence of certain disorders and not the presence of a genetic or anatomical disorder in the fetus.

These three components are used in this test along with information about the pregnancy, particularly its duration. This is important since levels of these markers vary throughout pregnancy.

Maternal Serum Screen 3; Triple Test in Pitampura and Rohini

Parameters Included in the Test

Parameters of the Maternal Serum Screen 3; Triple Test in Pitampura include the following:

  • BHCG TOTAL: Human Chorionic Gonadotropin measurement in maternal serum.
  • AFP: Alpha Feto Protein measurement (A protein produced during the development of the fetus).
  • ESTRIOL (E3): Estriol measurement (Estrogen hormone).

These indicators act as a whole set. The only indicator cannot be used as a diagnosis.

Maternal Serum Screen 3; Triple Test in Rohini – What Does It Assess?

Maternal Serum Screen 3; Triple Test, available at Rohini, helps in the prenatal screening of several medical issues such as trisomy 21 (Down Syndrome), trisomy 18, and some neural tube defects during the second trimester of pregnancy.

The result depends on various factors, including gestational age and others. Therefore, a healthcare provider should interpret the report based on the overall situation of the pregnancy.

Understanding the Three Biochemical Markers

Total β-hCG

The human chorionic gonadotropin hormone (hCG) is formed by the placenta during the period of pregnancy. The hormone is dynamic in its concentration in pregnancy; therefore, interpretation of the result is important. Regarding the triple screen test, the Total β-hCG helps in calculating the risk but does not provide a diagnosis independently.

Alpha-Fetoprotein (AFP)

AFP is a protein formed by the fetus during pregnancy. Maternal serum AFP plays an important role in the prenatal screening process and can be used in assessing the risks of structural abnormalities of the fetus, including neural tube defects. However, the levels of AFP are related to the pregnancy stage.

Estriol (E3)

Estriol is an estrogen hormone related to pregnancy that is formed as a result of the activity of the fetus and placenta. In the maternal serum test, estriol is considered in conjunction with the AFP and hCG results.

When Is the Triple Test Used?

The triple screen test is usually linked to the second trimester. Your physician or laboratory will need to know the appropriate dates of pregnancy when performing the test.

Maternal Serum Screen 3; Triple Test in Pitampura might be recommended for second-trimester prenatal testing. Your physician will tell you if the test will be appropriate for you.

Understanding Triple Test Results

A screening report estimates the likelihood of certain conditions using the measured markers and pregnancy information.

A report may indicate a lower or higher estimated risk. A higher-risk result does not mean the fetus definitely has a condition. Depending on the findings, the healthcare provider may suggest follow-up evaluation, such as ultrasound, genetic counselling, or diagnostic testing.

This is why the Maternal Serum Screen 3; Triple Test in Pitampura should be viewed as one part of prenatal care rather than a replacement for medical evaluation.

How Is the Test Performed?

The test will involve the collection of a maternal blood sample, which is normally done through a vein.

Make sure that you provide accurate information about the pregnancy, including gestational age.

Bio Diagnostics deals specifically with laboratory work and reporting for women who want to be screened for their pregnancy in Pitampura and Rohini.

Triple Test and Other Prenatal Screening Options

The choices for prenatal tests vary depending on the stages of pregnancy and other clinical factors. Other prenatal tests that could be recommended to a patient include the Dual Marker Test in Pitampura.

A similar prenatal screening test would be the Maternal Serum Screen 4; Quadruple Test in Pitampura. While the triple test has three hormones measured, the quadruple test has a fourth hormone called Inhibin A.

The test is specifically for the three marker panels including Total β-hCG, AFP, and E3.

Why Choose a Reliable Diagnostic Laboratory?

The results of the prenatal test can have an impact on healthcare choices, therefore, appropriate handling and reporting of samples is important. Bio Diagnostics offers laboratory testing services for Pitampura and Rohini residents.

Maternal Serum Screen 3; Triple Test in Rohini for Prenatal Screening

For those who are considering the test at Rohini, the above-mentioned panel of three markers will be helpful for second-trimester screening, under medical advice.

The Maternal Serum Screen 3; Triple Test at Rohini is just a screening test; hence, individuals should not misinterpret any of the individual markers.

Plan Your Prenatal Screening With Confidence

Maternal Serum Screen 3; Triple Test in Pitampura is a test that can give you helpful information regarding your risks when it is analysed along with other factors like gestational age. Maternal Serum Screen 3; Triple Test in Rohini is another clinic offering this three-marker test.

Ready to Schedule Your Test?

For laboratory facilities and prenatal screenings, please contact Bio Diagnostics for Maternal Serum Screen 3; Triple Test at Pitampura and Maternal Serum Screen 3; Triple Test at Rohini. Please consult your health care provider and make an appointment.